In the landmark Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial model [39], platelet counts, albumin, INR, and AST were associated with 1-year mortality in the HF population with implantable devices. This evidence concerns the gene ALB and hydrops fetalis.